Newsbenzinga
Reported Earlier, Dyne Therapeutics Prices Upsized $375M Public Offering Of 18.3M Common Shares At $20.50 Per Share
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…